MBTPS1 and neoplasm: The most direct in vivo evidence that S1P contributes to tumour angiogenesis comes from our recent publication that focused on a murine monoclonal antibody (mAb) designed to neutralise extracellular S1P by molecular absorption (Visentin et al, 2006).